Simplicity Wealth »

Outlook Therapeutics shares owned by Simplicity Wealth

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Simplicity Wealth from 13F filings

Historical chart of Simplicity Wealth investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Simplicity Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Simplicity Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $18k 11k 1.59

More positions owned by Simplicity Wealth

American Centy Etf Tr Us Eqt Etf (AVUS)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
American Centy Etf Tr Avantis Core Fi (AVIG)
Spdr Series Trust St Str P500etf (SPYM)
Alphabet Cap Stk Cl A (GOOGL)
American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Avantis Shfxdinc (AVSF)
American Centy Etf Tr Avantis Us Larg (AVLC)
Microsoft Corporation (MSFT)
Caterpillar (CAT)
Broadcom (AVGO)

View all positions for Simplicity Wealth

Top funds holding Outlook Therapeutics

Armistice Capital
Vanguard Capital Management
Gilpin Wealth Management
Geode Capital Management
BlackRock
Warberg Asset Management
Renaissance Technologies
Connective Capital Management
Citadel Advisors
Susquehanna International
Vanguard Fiduciary Trust
State Street Corporation
UBS Group
Simplex Trading
Group One Trading

View all funds holding Outlook Therapeutics